WE manufacture products that change lives™
About BioStem Technologies
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. Sinceour founding in 2014, we’ve pursued a singular goal: changing lives for the better with the power of superior processes and an unwavering commitment to innovation.
Leveraging our proprietary BioRetain® processing method, we manufacture perinatal tissue allografts at the highest levels of quality. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining natural growth factors and preserving tissue structure. Our allografts, including VENDAJE®,VENDAJE AC®, and VENDAJE OPTIC®, are trusted by top clinicians across a range of specialties.
We Manufacture Products That Change Lives™
We adhere to the highest quality standards set forth by prestigious industry regulators such as AATB® and FDA®.
Our motto is more than just a clever saying, it's how we govern our practices.
By developing novel approaches to industry changing processes, we focus on better than status quo.
What is Regenerative Medicine?
Soft tissue damage through disease and injury has catapulted the development of specialized therapies that can regenerate these tissues and decrease the reliance on limited steroidal treatments or addictive opioid prescriptions for pain. Regenerative medicine, on the whole, is an interdisciplinary field that applies engineering and life science principles to promote this regeneration with the hope of restoring the diseased or injured tissues.Get More Information
Using Perinatal Tissue In Regenerative Therapies
The first reported clinical use of perinatal-derived tissue allografts for aiding in wound healing was at Johns Hopkins over a century ago in 1910. In recent years, both clinical and research applications of these biomaterials have increased in scope to include roles in tissue engineering and regenerative medicine. Perinatal tissues are an abundant source of extracellular matrix components and growth factors, with potential use in a broad array of regenerative therapies. These components have translated well to regenerative applications owing to their low immunogenicity, positive wound healing characteristics, and minimal tissue inflammation1-2. The two most widely adopted perinatal components for clinical use are the umbilical cord and the amniotic membrane.Learn About Perinatal Tissue Components